Details about Philippe Beutels

Access statistics for papers by Philippe Beutels.

Last updated 2026-05-08. Update your information in the RePEc Author Service.

Short-id: pbe1475

Working Papers

2020

1. Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country
   LIDAM Reprints ISBA, Université catholique de Louvain, Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA) View citations (1)

2015

2. The future’s so bright, I gotta wear sunscreen: Dispositional optimism and preferences for prioritizing health care
   Working Papers, University of Antwerp, Faculty of Business and Economics

2014

3. Health-related quality of life in patients with melanoma expressed as utilities and disability weights
   LIDAM Reprints ISBA, Université catholique de Louvain, Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA) View citations (1)

2013

4. Public preferences for prioritizing preventive and curative health care interventions: A discrete choice experiment
   Working Papers, University of Antwerp, Faculty of Business and Economics View citations (14)

2008

5. The macroeconomic costs of a global influenza pandemic
   Conference papers, Purdue University, Center for Global Trade Analysis, Global Trade Analysis Project

Journal Articles

2026

1. Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms
   PLOS ONE, 2026, 21, (3), 1-17

2025

2. Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis
   Nature Communications, 2025, 16, (1), 1-14

2023

3. Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
   The European Journal of Health Economics, 2023, 24, (6), 909-922
4. The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach
   PLOS Medicine, 2023, 20, (7), 1-25

2022

5. Authors’ Reply to Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”
   PharmacoEconomics, 2022, 40, (10), 1013-1014
6. Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine
   PharmacoEconomics, 2022, 40, (4), 461-476
7. Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2
   PLOS Computational Biology, 2022, 18, (8), 1-20
8. Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice
   Medical Decision Making, 2022, 42, (4), 421-435 View citations (1)
9. Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment
   Social Science & Medicine, 2022, 303, (C)

2021

10. COVID-19 and retail: The catalyst for e-commerce in Belgium?
    Journal of Retailing and Consumer Services, 2021, 62, (C) View citations (40)
11. The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19
    Nature Communications, 2021, 12, (1), 1-9 View citations (3)

2020

12. A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations
    Medical Decision Making, 2020, 40, (5), 669-679 View citations (1)
13. Recent quantitative research on determinants of health in high income countries: A scoping review
    PLOS ONE, 2020, 15, (9), 1-21 View citations (2)

2018

14. Effectiveness of a Malaria Surveillance Strategy Based on Active Case Detection during High Transmission Season in the Peruvian Amazon
    IJERPH, 2018, 15, (12), 1-20
15. Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives
    Social Science & Medicine, 2018, 207, (C), 106-116 View citations (10)
16. Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination
    Medical Decision Making, 2018, 38, (6), 730-745

2017

17. The Cost of Arbovirus Disease Prevention in Europe: Area-Wide Integrated Control of Tiger Mosquito, Aedes albopictus, in Emilia-Romagna, Northern Italy
    IJERPH, 2017, 14, (4), 1-22 View citations (3)

2016

18. Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges
    PharmacoEconomics, 2016, 34, (8), 723-731
19. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
    PharmacoEconomics, 2016, 34, (3), 227-244 View citations (4)
    Also in PharmacoEconomics, 2016, 34, (3), 227-244 (2016) View citations (4)

2015

20. Medicine price awareness in chronic patients in Belgium
    Health Policy, 2015, 119, (2), 217-223

2014

21. Data mining for longitudinal data under multicollinearity and time dependence using penalized generalized estimating equations
    Computational Statistics & Data Analysis, 2014, 71, (C), 667-680 View citations (2)
22. Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All
    PLOS ONE, 2014, 9, (7), 1-11 View citations (6)

2013

23. Evolutions in Both Co-Payment and Generic Market Share for Common Medication in the Belgian Reference Pricing System
    Applied Health Economics and Health Policy, 2013, 11, (5), 543-552 View citations (3)
24. Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study
    Social Science & Medicine, 2013, 77, (C), 84-89 View citations (1)
25. Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability
    PharmacoEconomics, 2013, 31, (8), 693-702 View citations (2)

2012

26. Economic Evaluations of Childhood Influenza Vaccination
    PharmacoEconomics, 2012, 30, (8), 647-660

2011

27. Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models
    Medical Decision Making, 2011, 31, (4), 675-692 View citations (24)
28. Revealing age-specific past and future unrelated costs of pneumococcal infections by flexible generalized estimating equations
    Journal of Applied Statistics, 2011, 38, (8), 1533-1547

2010

29. Estimating infectious disease parameters from data on social contacts and serological status
    Journal of the Royal Statistical Society Series C, 2010, 59, (2), 255-277 View citations (6)
30. The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands
    The European Journal of Health Economics, 2010, 11, (6), 543-554 View citations (58)
31. The possible macroeconomic impact on the UK of an influenza pandemic
    Health Economics, 2010, 19, (11), 1345-1360 View citations (62)

2009

32. Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium
    Medical Decision Making, 2009, 29, (1), 33-50 View citations (7)
33. Estimating the Incidence of Symptomatic Rotavirus Infections: A Systematic Review and Meta-Analysis
    PLOS ONE, 2009, 4, (6), 1-10
34. Reviewing the Cost Effectiveness of Rotavirus Vaccination
    PharmacoEconomics, 2009, 27, (4), 281-297 View citations (2)

2008

35. Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern
    Health Economics, 2008, 17, (11), 1317-1322 View citations (22)
36. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
    PLOS Medicine, 2008, 5, (3), 1-1 View citations (201)

2007

37. Estimation of the Force of Infection from Current Status Data Using Generalized Linear Mixed Models
    Journal of Applied Statistics, 2007, 34, (8), 923-939

2004

38. Do costs of varicella justify routine infant vaccination?
    The European Journal of Health Economics, 2004, 5, (1), 54-57

2003

39. Economic Evaluations of Varicella Vaccination Programmes
    PharmacoEconomics, 2003, 21, (1), 13-38 View citations (4)
40. Modelling forces of infection by using monotone local polynomials
    Journal of the Royal Statistical Society Series C, 2003, 52, (4), 469-485

2001

41. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)
    Health Economics, 2001, 10, (8), 751-774 View citations (6)